Fenozolone
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | N06BA08 (WHO) |
Identifiers | |
|
|
CAS Number | 15302-16-6 ![]() |
PubChem (CID) | 71682 |
ChemSpider | 64736 ![]() |
UNII | 1NZI4LMU6G ![]() |
KEGG | D07344 ![]() |
ChEMBL | CHEMBL2104907 |
ECHA InfoCard | 100.035.747 |
Chemical and physical data | |
Formula | C11H12N2O2 |
Molar mass | 204.225 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
|
|
|
|
(verify) |
Fenozolone (Ordinator) was developed by Laboratoires Dausse in the 1960s[1] and is a psychoactive drug and stimulant related to pemoline and 4-methylaminorex which acts as a norepinephrine-dopamine releasing agent (NDRA).[2]
See also[edit]
References[edit]
- ^ DE Patent 1297108B - 5-phenyl-2-ethylamino-4-oxazolinone and its preparation
- ^ Gielsdorf W (February 1982). "Determination of the psychostimulants pemoline, fenozolone and thozalinone in human urine by gas chromatography/mass spectrometry and thin layer chromatography". Journal of Clinical Chemistry and Clinical Biochemistry. 20 (2): 65–8. PMID 6121837.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |